Related Experiment Videos
Circulating monocytes from healthy individuals and COPD patients
Ruta Aldonyte1, Lennart Jansson, Eeva Piitulainen
1Department of Internal Medicine, University Hospital Malmo, Sweden. ruta.dominaitiene@medforsk.mas.lu.se <ruta.dominaitiene@medforsk.mas.lu.se>
Respiratory Research
|November 20, 2003
Summary
Monocytes from COPD patients show altered release of inflammatory molecules compared to healthy individuals. Alpha1-antitrypsin deficiency also impacts tumor necrosis factor-alpha secretion in COPD.
Area of Science:
- Immunology
- Pulmonary Medicine
- Genetics
Background:
- Chronic obstructive pulmonary disease (COPD) involves airflow obstruction and inflammation, with monocytes/macrophages as key cells.
- Alpha1-antitrypsin (AAT) deficiency (PiZZ genotype) is the sole known genetic risk factor for COPD.
Purpose of the Study:
- To compare pro-inflammatory molecule release from monocytes in healthy individuals versus COPD patients.
- To investigate the influence of AAT deficiency on monocyte inflammatory responses.
Main Methods:
- Blood monocytes were isolated from healthy (n=30) and COPD (n=20) individuals.
- Monocytes were cultured and stimulated with lipopolysaccharide (LPS) to assess basal and stimulated release of inflammatory molecules.
Main Results:
- COPD monocytes exhibited higher basal release of MMP-9 and lower IL-8 compared to controls.
- LPS-stimulated release of IL-6 and MCP-1 was elevated in COPD monocytes, while ICAM-1 and MMP-9 were higher in controls.
- Monocytes from PiZZ AAT carriers released significantly less TNFalpha, irrespective of COPD status.
Conclusions:
- Circulating monocyte secretion of specific pro-inflammatory molecules differs between healthy and COPD subjects.
- These findings contribute to understanding inflammatory cell recruitment and activation mechanisms in COPD.